돌아가기
Huagongshe화공사 화학 정보 인쇄 보고서 · 연구 참고용
HRID 1281007생성일: 2026년 10월 23일

Diisopropylcarbodiimide → 4-[[N-(3-bromo-4-methylbenzoyl)glycyl]aminomethyl]-1-(4-chlorobenzyl)piperidine

https://huagongshe.com/ko/reaction/1281007

반응식

참여 물질

역할이름HCID투입량
반응물DiisopropylcarbodiimideHCID 12734—
반응물1-HydroxybenzotriazoleHCID 75771—
반응물3-Bromo-4-methylbenzoic acidHCID 82130—
반응물1-(4-Chlorobenzyl)-4-((glycylamino)methyl}piperidineHCID 18426155—
용매ChloroformHCID 6212—
용매tert-ButanolHCID 6386—
생성물4-[[N-(3-bromo-4-methylbenzoyl)glycyl]aminomethyl]-1-(4-chlorobenzyl)piperidineHCID 18426237—

반응 단계

A solution of 1-(4-chlorobenzyl)-4-{(glycylamino)methyl)piperidine (0.050 mmol) in CHCl3 (1.35 mL) and tert-butanol (0.15 mL) was treated with 3-bromo-4-methylbenzoic acid (0.060 mmol), diisopropylcarbodiimide (0.060 mmol), and HOBt (0.060 mmol). The reaction mixture was stirred at room temperature for 15 h. The mixture was loaded onto Varian™ SCX column, and washed with CH3OH/CHCl3 1:1 (12 mL) and CH3OH (12 mL). Product was eluted off using 2 N NH3 in CH3OH (5 mL) and concentrated to afford 4-[{N-(3-bromo-4-methylbenzoyl)glycyl}aminomethyl]-1-(4-chlorobenzyl)piperidine (Compound No. 1113) (16.1 mg, 65%): The purity was determined by RPLC/MS (95%); ESI/MS m/e 494.0 (C23H27BrClN3O2).

출처 및 근거

DOI10.6084/m9.figshare.5104873.v1
특허 번호US06451842B1
출처 데이터셋uspto-grants-2002_09
ORD IDord-9ed96c40a20c423e96ea478b1b68b1e3
출처 메모uspto-grants-2002_09